Obesity is a morbid physical condition. Obesity can cause many diseases. What gynecological diseases can obesity cause? It is well known that obese people are prone to cardiovascular and cerebrovascular diseases such as hypertension, diabetes, coronary heart disease, arteriosclerosis, and stroke. However, in women, obesity is also closely related to the occurrence of certain gynecological tumors. A large number of clinical data show that obese women are prone to endometrial cancer, and its incidence is higher than that of thin women. Why? Because the incidence of endometrial cancer is mainly related to economic conditions, diabetes, hypertension, obesity, pregnancy and childbirth, menstrual diseases, and the impact of estrogen, with the improvement of living standards, the better the economic conditions, the higher the incidence. Because obesity and diabetes are often associated with diabetes, endometrial cancer is also more common because of diabetes. Obese people suffer from high blood pressure, and endocrine hormones are often disordered. Among them, estrogen is the main factor that induces endometrial cancer. If female sex hormones are excessively synthesized, those excess estrogens are lipidated and stored in adipose tissue, which increases the amount of estrogen stored in fat cells, and at the same time, the estrogen stored in fat cells can be continuously released into the bloodstream. , the metabolism is slow, and it has a continuous effect on the endometrium. Under the long-term effect of estrogen, the endometrium is prone to cancer, especially in obese menopausal women, the incidence of endometrial cancer is 2 to 4 times that of non-obese women, which should arouse the high vigilance of the medical community and obese women .
Obesity is a high risk factor for endometrial cancer. To reduce the incidence of endometrial cancer, it is necessary to control obesity and reduce the degree of obesity. Generally speaking, every obese woman should regularly measure blood pressure, blood sugar and urine sugar. Because obesity is accompanied by diabetes and high blood pressure at the same time, this is an extremely dangerous signal for endometrial cancer. Once these high-risk groups have menstrual disorders, delayed menopause or abnormal vaginal bleeding after menopause, they should go to the hospital for examination as soon as possible. Clinical observation shows that endometrial cancer occurs in prolific, nulliparous and infertile cases. Therefore, obese women with menstrual disorders should use estrogen with caution. Progesterone can be used to stop bleeding and adjust the menstrual cycle. After 2 to 3 cycles of treatment ineffective, diagnostic curettage should be performed to clarify the endometrial condition. For obese women in menopause and menopause, they should be more vigilant, because this age is the age of high incidence of endometrial cancer. Once women have irregular vaginal bleeding after menopause, early symptoms such as yellow watery leucorrhea or bloody leucorrhea in the vagina, they should go to the hospital for diagnosis and treatment as soon as possible. It is worth mentioning that some patients are reluctant to perform diagnostic curettage, and they propose to replace diagnostic curettage with gynecological and B-ultrasound examinations, or even CT examinations. This can easily delay treatment. At present, the most effective and reliable diagnostic methods for endometrial cancer are curettage and endometrial biopsy for pathological examination. The patient should undergo this examination.
The life of menopausal women tends to be stable. In addition, the current economic situation is gradually improving, the living standard is improving, the daily labor is reduced, the energy consumption is reduced, the rest time is increased, and the dietary conditions are getting better and better. These factors can lead to obesity in menopause. Therefore, women entering menopause should regularly carry out appropriate physical exercise to control the occurrence and development of obesity during menopause, so as to prevent the occurrence of endometrial cancer.
